Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Forging the Future: Standardization and Innovation in Post-Quantum Cryptography
-
Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome
-
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
-
Statement by the Prime Minister on the 30th commemoration of the Genocide against the Tutsi in Rwanda
-
LBank Exchange Will List Kendu Inu (KENDU) on April 10, 2024
-
BDPlayground (BDP) Is Now Available for Trading on LBank Exchange
-
Statement by the Prime Minister on World Health Day
-
Nucific Invites You To Nuture Your Gut Microbiome and Celebrate World Health Day with Nucific Bio-X4
-
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
-
CorVista Health to Present New Data on the Use of Machine Learning as a Non-Invasive Point-of-Care Rule-out Test for Heart Failure at ACC 2024
-
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
-
Clean Smarter, Not Harder: Tineco's Spring Cleaning Sale is Here
-
AndaSeat Kaiser 4: Experience Next-Level Comfort and Sustainability! A One-of-a-Kind Early Bird Special!
-
New survey uncovers lack of awareness around heart valve disease and risk factors among women
-
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
-
EHang Secures Production Certificate from CAAC, Clearing Path for Mass Production of EH216-S Pilotless eVTOL Aircraft
-
FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
-
Errante Group Launches Methods to Email Like a Boss: Elevating Emailing Game with AI
-
Ensurge Micropower ASA - Approval of share capital increase by conversion of convertible loan
-
Flash News: OKX Wallet Now Integrated with SHUI, a Leading Liquid Staking Protocol
-
Thành tựu mới nhất của Pin mặt trời dị hợp silicon tinh thể LONGi được công bố trên tạp chí Nature: Mỏng hơn cả giấy A4
-
ความสำเร็จล่าสุดของ LONGi ด้านเซลล์แสงอาทิตย์ชนิดเฮเทโรจังค์ชันแบบผลึกซ�
-
ซูมไลออนเตรียมเดบิวต์อย่างยิ่งใหญ่ที่งานอินเตอร์แมตในปารีส
-
กลุ่มพันธมิตร CASI จัดงานแบบเจอหน้าเจอตัวครั้งแรก มุ่งส่งเสริมความร่วมม�
-
Golden Visa Experts Hungary Paves the Path to Streamlined Immigrant Investor Programs in Europe
-
Silver Birch Therapy Brings Rawness, Humor, and Realness to Online Talk Therapy in Minnesota and North Dakota
-
Contractor Publishes Case Study Detailing Brighton, CO Veterans Memorial Project
-
Zoomlion will make a significant debut at the INTERMAT in Paris
-
Zoomlion will make a significant debut at the INTERMAT in Paris
-
Angelalign Announces Solid Progress in 2023
-
Lynk & Co thâm nhập vào thị trường Philippines và chuẩn bị có những bước tiến lớn tại Đông Nam Á
-
ลิงค์ แอนด์ โคจะเปิดธุรกิจที่ฟิลิปปินส์และเดินหน้าเติบโตในเอเชียตะวั
-
MINISO Opens its First Malaysian IP Collection Store in Barbie-inspired Style
-
NYCB DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against New York Community Bancorp, Inc. and Encourages Investors to Contact the Firm
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Equinix, Inc. Investors to Inquire About Securities Class Action Investigation – EQIX
-
GLG Life Tech Corporation Announces New Meeting Date for Special Shareholder Meeting
-
Association of Black Cardiologists' "We Are The Faces" Campaign Unveils New Videos for Black Maternal Health Week
-
Call for Victoria Police and anti-corruption watchdog to investigate alleged secret deal and militant union threats to Victoria's Premier
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages JBS S.A. Investors to Inquire About Securities Class Action Investigation – JBSAY
-
Canopy Management Wins Spot on Inc. Magazine's Prestigious Fastest Growing Companies List for 2024
-
Frederik Bussler, owner of Bussler & Co, accepted into Forbes Agency Council
-
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
-
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
-
Automated Assets Groups Takes New Steps to Enhance E-commerce trading with Advanced Services and Partner Support
-
Noble Capital Markets Brings the ‘Sharks’ to Boca for NobleCon20
-
Gate.io Participated In The 2024 Hong Kong Web3 Festival Along With Other Industry Leaders
-
egnite, Inc. and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
-
SNOW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Snowflake Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophr
-
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research So
